DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



MRI Homepage

Riccardo Lattanzi National Academy of Engineering selects young MR researcher for prestigious frontiers of engineering symposium

MR machine rented to scan single terrorist at Guantánamo doesn't work Liquid helium dissipated for unknown reasons

MGH team develops a potential alternative to gadolinium-based contrast agents Made of the vital element manganese

MR imaging breaks new ground for depression and anxiety research Shows structural similarities and differences

Elekta to add functional imaging capabilities and take more time to validate MR-linac system Expects CE approval in first half of 2018

Aspect Imaging scores CE mark for its Embrace Neonatal MR system Already in use in Israel

Updated guidelines recommend use of S-ICDs for patients with ventricular arrhythmia Call to action for physicians

Study cautions against trust in MR results for axial spondyloarthritis MR scans are prone to produce positive results for axSpA in healthy individuals

Mallinckrodt Institute of Radiology installs first Siemens MAGNETOM Vida in the US First Siemens MR scanner to carry BioMatrix technology

MR study shows how different football positions impact brain damage First time DTI and fMRI used in conjunction

Children's National Health System is
the first U.S. pediatric institution to
perform MR-HIFU to treat osteoid osteoma

Children’s National Health System first U.S. pediatric institution to use MR-HIFU

by John Fischer , Staff Reporter
Doctors at Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System have identified a new technique that uses MR and ultrasound technology to remove bone tumors in children.

Children’s National is the first children’s hospital in the U.S. to perform magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) as a noninvasive alternative for treating osteoid osteoma, compared to the standard practice of radiofrequency ablation and surgery. The findings of its physicians were published in The Journal of Pediatrics.

Story Continues Below Advertisement

The (#1 Resource) for Medical Imaging and Peripherals. Call 1-949-273-8000

As a Master Distributor for major brands Barco, Philips, and Sony, we offer custom imaging solutions. With our renowned OEM Solutions and Service/Repair Center, Ampronix is a one-stop shop for HD Medical LCD Displays--Printers--Recorders--4K Cameras

“MR-guided HIFU is different from other techniques in that it is completely noninvasive. There is no requirement for any sort of incision … in radiofrequency ablation, a bone drill is used to find the osteoid osteoma under CT guidance,” said Dr. Karun Sharma, director of Interventional Radiology at Children's National and principal investigator for the osteoid osteoma trial. “MR-HIFU is done with MR guidance, and there’s no ionizing radiation exposure with MR.”

The use of MR-HIFU is part of the Image-Guided Noninvasive Therapeutic Energy (IGNITE) program, a collaboration between Sheikh Zayed Institute and the departments of Radiology, Oncology, Surgery, and Anesthesiology at Children's National that aims to develop technology for minimally invasive and noninvasive surgery and combination therapy approaches that improve quality of life and outcome for pediatric patients.

MR-HIFU uses focused sound wave energy to heat up and destroy tumors under the guidance of MR. This reduces risks of infection and bone fracture. It is also faster, compared to CT-guided RFA and other methods, with an estimated completion time of 90 minutes or less.

A clinical trial examined and compared nine patients who underwent MR-HIFU to nine who underwent CT-guided RFA. All patients were between the ages of 6 and 16. Those who underwent MR-HIFU were between 6 and 16 and those who underwent CT-guided RFA were between 6 and 10. The results found that MR-HIFU is a more feasible and safe method, eliminating risks of incision and ionizing radiation compared to the use of RFA.

“It is noninvasive, so there is much less collateral damage than surgery, for instance, where you’re not disrupting surrounding, normal tissue,” said Sharma. “It’s precise in that way. The other thing is we’re more sensitive about exposing children to ionizing radiation.”

MR-HIFU is authorized to treat uterine fibroids, prostate cancer, essential tremor and bone metastases of several types of cancers in adults. There is hope that the technology will one day expand into treatment for brain conditions, such as epilepsy and seizures.

Sharma says that such technology has the potential to become “commonplace”, and perhaps a standard tool one day for adults and children.

“I think there is a lot of potential for this technology in pediatrics … we’re still early in the game, and we have to do the clinical trials, but for certain applications, it holds a lot of promise,” he said.

Children's National is currently studying the technique in two other pediatric clinical trials, for desmoid tumors and sarcoma.

MRI Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2017, Inc.